Navigation Links
Welch Allyn Suresight™ Vision Screener (English)

ProductsWelch Allyn Suresight™ Vision Screener (English)
Company Welch Allyn Medical Products
Item Welch Allyn Suresight™ Vision Screener (English)
Features Five-second, automatic test addresses compliance problems and makes testing easier. Lights and sounds engage the patient's attention. Automatically measures and indicates abnormal readings - no provider interpretation is required. Operates at a non-threatening 14-inch (35 cm) distance. Requires minimal cooperation, making it ideal for use on young children, the disabled, and when there is a language barrier. Screens for common vision problems, including near- and farsightedness (myopia/hyperopia), astigmatism (asymmetrical focus), and anisometropia (unequal power between eyes).
Description A child-friendly vision test that's automatic, objective, and takes just seconds. Welch Allyn created Suresight™, the first objective, accurate vision test that ensures reliable early detection of refractive error, the primary vision disorder in children.
Info Welch Allyn Medical Products
Customer Service: (800) 535-6663
Web site: http://www.welchallyn.com/medical/

Related medicine products :

1. Welch Allyn PanOptic Ophthalmoscope with Cobalt-Blue Filter and Corneal Viewing Lens
2. Welch Allyn PanOptic Ophthalmoscope
3. Welch Allyn 2.5v PocketScope Ophthalmoscope with AA battery handle in soft carrying case
4. Welch Allyn 2.5v PocketScope Ophthalmoscope with AA battery handle
5. Welch Allyn 2.5v PocketScope Ophthalmoscope (without Handle)
6. Welch Allyn Prestige Coaxial-plus Ophthalmoscope (Head Only)
7. Welch Allyn Video Direct Ophthalmoscope (Head Only)
8. Welch Allyn Binocular Indirect Ophthalmoscope with Diffuser Filter
9. Welch Allyn 3.5v AutoStep Coaxial Ophthalmoscope Head Only
10. Welch Allyn Wall/Desk Power Source for Binocular Indirect Ophthalmoscope
11. Optec 3500 Vision Tester
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 1U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 2U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 3U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 4U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 5West to Present at Two Upcoming Investor Conferences 56960 1West to Present at Two Upcoming Investor Conferences 56960 2Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 1Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 2